NIPBL and non-small cell lung carcinoma: Given that the STAT3-related pathway is constitutively activated in diverse cancers, and acts as a potent pro-survival and anti-apoptotic signaling protein, these data demonstrated that NIPBL silencing inhibited cell growth, possibly via downregulating STAT3 and STAT3 target genes in NSCLC cells.